HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells.

Abstract
CD8(+) effector T cells recognize malignant cells by monitoring their surface for the presence of tumor-derived peptides bound to MHC class I molecules. In addition, tumor-derived Ags can be cross-presented to CD8(+) effector T cells by APCs. IFN-gamma production by CD8(+) T cells is often critical for tumor rejection. However, it remained unclear whether 1) CD8(+) T cells secrete IFN-gamma in response to Ag recognition on tumor cells or APCs and 2) whether IFN-gamma mediates its antitumor effect by acting on host or tumor cells. We show in this study that CD8(+) effector T cells can reject tumors in bone marrow-chimeric mice incapable of cross-presenting Ag by bone marrow-derived APCs and that tumor rejection required host cells to express IFN-gammaR. Together, CD8(+) effector T cells recognize Ag directly on tumor cells, and this recognition is sufficient to reject tumors by IFN-gamma acting on host cells.
AuthorsThomas Schüler, Thomas Blankenstein
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 170 Issue 9 Pg. 4427-31 (May 01 2003) ISSN: 0022-1767 [Print] United States
PMID12707316 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Receptors, Interferon
  • interferon gamma receptor
  • Interferon-gamma
  • Ovalbumin
Topics
  • Animals
  • Antigen Presentation (immunology)
  • Antigen-Presenting Cells (immunology, metabolism)
  • Antigens, Neoplasm (immunology, metabolism)
  • Bone Marrow Cells (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • Graft Rejection (immunology)
  • Interferon-gamma (metabolism, physiology)
  • Melanoma, Experimental (immunology, metabolism, prevention & control)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Ovalbumin (immunology, metabolism)
  • Receptors, Interferon (biosynthesis, physiology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: